Zynerba Pharmaceuticals
Pharmaceutical company developing transdermal cannabinoid therapeutics for behavioral and emotional conditions.
About
Technology stack
detected 2026-05-23No comments yet. Be the first to share your take.
What does Zynerba Pharmaceuticals do?
Zynerba Pharmaceuticals was a specialty pharmaceutical company focused on developing and commercializing novel transdermal cannabinoid therapeutics. Their lead product candidates were designed to treat behavioral and emotional symptoms associated with conditions such as Fragile X syndrome, developmental and epileptic encephalopathies, and peripheral neuropathic pain. The company aimed to leverage the therapeutic potential of cannabinoids through innovative drug delivery systems.
Where is Zynerba Pharmaceuticals headquartered?
Zynerba Pharmaceuticals is headquartered in Wayne, United States.
When was Zynerba Pharmaceuticals founded?
Zynerba Pharmaceuticals was founded in 2007.
What industry does Zynerba Pharmaceuticals operate in?
Zynerba Pharmaceuticals operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Mental Health Tech, Cannabinoid Therapeutics.
What is Zynerba Pharmaceuticals's current status?
Zynerba Pharmaceuticals's current operating status is: Inactive.